Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corporation reports developments across a diversified healthcare services business that combines ambulatory surgery, hospital operations and healthcare-services outsourcing. Its care delivery network includes United Surgical Partners International, which operates ambulatory surgery centers and surgical hospitals, along with acute care and specialty hospitals, outpatient facilities, employed physician networks and a global business center in Manila.
Recurring news themes for THC include quarterly earnings, financial outlooks, same-facility revenue trends, Ambulatory and Hospital segment performance, payer-mix and expense-management commentary, and capital or ownership actions involving Conifer Health Solutions. Company updates also cover Conifer's revenue cycle management and value-based care services for hospitals, health systems, physician practices, employers and other clients, as well as Tenet's presentations at healthcare investor conferences.
Tenet Healthcare Corporation (NYSE: THC) announced its decision to retain its subsidiary, Conifer Health Solutions, after evaluating shareholder value creation opportunities. This choice was influenced by significant improvements in financial metrics, including a 1,000 basis point increase in Conifer's Adjusted EBITDA margin since 2017. Expectations project mid- to high-single digit revenue growth for Conifer in FY 2022, bolstered by new client acquisitions and a strong cash flow profile. Tenet reaffirmed its financial outlook for FY 2022 in this context.
Tenet Healthcare Corporation (NYSE: THC) announced the redemption of all $700 million of its 7.500% senior secured first lien notes due April 1, 2025. The redemption will occur on February 23, 2022, using available cash, resulting in a total expected cost of approximately $730 million. This strategic move will reduce future annual cash interest payments by around $53 million, indicating a proactive effort to improve financial health.
Tenet Healthcare Corporation (NYSE: THC) reported Q4’21 net income of $250 million ($2.30 per diluted share), a decline from $414 million ($3.86 per diluted share) in Q4’20. Adjusted EBITDA fell to $1.017 billion from $1.278 billion year-over-year. For FY 2021, net income rose to $915 million, with adjusted diluted EPS of $7.58. The company is optimistic about FY 2022, projecting income per share between $4.56 and $6.16 and adjusted EBITDA of $3.375 to $3.575 billion. Tenet also acquired 86 surgery centers, enhancing its growth strategy.
GI Alliance has formed a new joint venture with United Surgical Partners International (USPI) to enhance gastroenterology services in Texas. The joint venture holds a majority stake in two endoscopy centers in San Antonio and Lubbock, Texas, which are accredited by reputable organizations. This partnership aims to provide high-quality outpatient care and allows physicians to maintain focus on patient care. GI Alliance supports over 665 gastroenterologists across multiple states, while USPI operates over 430 ambulatory facilities nationwide.
Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter results for the period ending December 31, 2021, after market close on February 7, 2022. A conference call is scheduled for February 8, 2022, at 10:00 a.m. Eastern time to discuss the results. Investors can access a live webcast and the audio archive via the investor relations section of Tenet's website.
Tenet operates a vast care network, including 60 hospitals and approximately 550 other healthcare facilities. Their mission is to provide quality, compassionate care in the communities they serve.
Tenet Healthcare Corporation (NYSE: THC) will present virtually at the J.P. Morgan Healthcare Conference on January 11, 2022, at 3:00 p.m. Eastern time. A live webcast, along with an audio archive of the event, can be accessed through the investor relations section of Tenet's website, with a replay available for 30 days. Tenet operates a wide range of healthcare services, including 60 hospitals and approximately 550 other healthcare facilities. Their mission is to provide quality, compassionate care to communities served.
Tenet Healthcare Corporation (NYSE: THC) has successfully acquired SurgCenter Development (SCD) for approximately $1.1 billion. This acquisition includes 86 ambulatory surgery centers (ASCs) and related support services. Additionally, USPI, a subsidiary of Tenet, is seeking to acquire up to $250 million in equity from physician owners of these ASCs. The phased consolidation is expected to yield an estimated fully ramped Adjusted EBITDA of $275 million within three to four years. USPI aims to partner with SCD to develop at least 50 new centers over five years.
Tenet Healthcare Corporation (NYSE: THC) is set to present at the BofA Securities Leveraged Finance Conference on November 30, 2021, starting at 9:45 a.m. ET. A live webcast will be accessible in the investor relations section of Tenet's website and will be available for replay for 30 days. Headquartered in Dallas, Tenet operates over 60 hospitals and approximately 460 healthcare facilities, employing over 100,000 individuals. Tenet is dedicated to providing quality care across its expansive network.
Tenet Healthcare Corporation (NYSE: THC) announced the retirement of Regina Nethery, Vice President of Investor Relations, effective at the end of 2021. Nethery's tenure was marked by significant contributions, earning recognition as one of the best Investor Relations professionals by Institutional Investor. Dan Cancelmi, CFO, and Ron Rittenmeyer, Executive Chairman, expressed gratitude for her strategic counsel and dedication. Tenet is currently conducting a national search for her replacement with Russell Reynolds Associates.
Tenet Healthcare Corporation (NYSE: THC) announced the pricing of a private placement offering of $1.45 billion in senior secured first lien notes due January 15, 2030, with a 4.375% interest rate. The offering is expected to close on December 1, 2021, subject to market conditions. Proceeds will finance the acquisition of Surgical Center Development's ownership interest in 92 ambulatory surgery centers, with excess funds for general corporate purposes, including debt repayment. The offering is not registered under the Securities Act, limiting its distribution.